Pfizer closure a blow to science and growth confidence

Whilst Pfizer are saying that their closure of their Kent-based research site is due to internal changes in priorities it highlights both fundamental changes in the approach to drug research and development (R&D) and the urgent need for the UK government to know how to keep companies in the UK.

In order to build confidence in the UK, questions we need to be acting on the answers to as soon as possible include:

  • How quickly can we implement Sir Michael Rawlins’ report to encourage growth clinical trials in the UK?
  • We are still one of the lowest spenders on medicines of the OECD nations and our spend has been falling since 1994 according to their data – why aren’t we doing more to encourage the use of new drugs?
  • What is being done to encourage pupils to study science at A level and beyond to ensure an adequate workforce?
  • What are the barriers to universities developing new chemical entities and forming SMEs to commercialize them and enable re-investment?
  • Has anyone done the work on the longer term costs of research moving East? Costs will rise in India and China over time. Is there a period over which we can predict we should offer more incentives in the UK, knowing that eventually what we can offer here will be overall better value than can be found in the East?
  • Drug R&D is hugely expensive and risky and companies say that the UK is one of the most expensive countries in which to undertake it. Why – and what can we change?

No doubt the Budget will be seeking to stimulate growth, but that is 7 weeks away. Unequivocal, public decisions need to be taken now based on what we already know to ensure we retain, attract and develop our pharmaceutical base in the UK.


About Julia Manning

Julia Manning is a social pioneer, writer, campaigner and commentator. Formerly a clinical optometrist specialising in diabetes and visual impairment, she is the founder and Director of 2020health, an independent, social enterprise Think Tank whose aim is to Make Health Personal and Social. 2020health has through research, events and campaigning influenced opinion and action in fields as diverse as bioethics, alcohol, emerging technologies, fraud, education, consumer technology and vaccination. In 2014, 2020health were founding partners of the Health Tech and You Awards with Axa PPP and the Design Museum. Since 2016, 2020health has increasingly focused on digital health and public health in the community. Julia is a Fellow of the RSA and now also a part-time PhD student at the UCL Interaction Centre, studying the use of digital technology for stress management in the workplace. Julia has shared 2020health's research widely in the media (BBC News, ITV, Channel 5 News, BBC 1′s The Big Questions & Victoria Derbyshire, BBC Radio 4 Today, PM and Woman's Hour, LBC) and has taken part in debates and contributed to BBC’s Newsnight, Panorama, You and Yours and ITV’s The Week.
This entry was posted in Drugs, Pharma and tagged , , , , , . Bookmark the permalink.

Leave a Reply

Please log in using one of these methods to post your comment: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s